Innovative technologies and research in the areas of Genomics, Proteomics, Bioinformatics and Robotics are currently revolutionizing pharmaceutical research. Novartis aims to apply its expertise in these new areas of research to the investigation of infectious diseases. We view this as a long-term commitment to enhancing the discovery of preventative and effective treatments for diseases like tuberculosis (TB) and Dengue Fever.